20–21 Jan 2022
Birla Institute of Technology
Asia/Kolkata timezone

Phytocompounds in drug discovery and development: Control of cancer and antibiotic resistance

20 Jan 2022, 10:30
1h
Birla Institute of Technology

Birla Institute of Technology

Mesra, Ranchi 835 215, Jharkhand, India
Keynote Lecture Interdisciplinary Keynote Lecture

Speaker

Prof. Velmurugan Devadasan (University of Madras (Guindy Campus), Madras)

Description

Herbal medicine is widely used globally to treat various diseases. Even though it does not lead to an immediate cure, the side effects are less compared to allopathic medicine. Cancer is one of the dreadful diseases killing millions of people worldwide. Antibiotic resistance is the major problem to tackle now as resistance had developed to many antibiotics. Discovery of new antibiotics is very much delayed. In both the problems herbal medicine comes as a remedy. Literature shows that there are phytocompounds which can control/cure various types of cancer and also some of them act alone as antibacterials or act as adjuvants along with the resistant antibiotics in reversing the antibiotic resistance. The presentation will cover the research outcome related to the above two problems based on the work carried out in herbal medicine for the past 15 years. Details will be presented on the role of a phytocompound from a rhizome in treating colon cancer, breast cancer and lung cancer. Some novel herbs will be discussed. To validate the above said properties of the herbs, molecular docking had also been carried out for the related phytocompounds with relevant targets along with the drugs being used to treat the ailments.

Primary author

Prof. Velmurugan Devadasan (University of Madras (Guindy Campus), Madras)

Presentation materials

There are no materials yet.